Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSD428650 S
Publication typeGrant
Application numberUS 29/101,529
Publication dateJul 25, 2000
Filing dateMar 5, 1999
Priority dateSep 8, 1998
Publication number101529, 29101529, US D428650 S, US D428650S, US-S-D428650, USD428650 S, USD428650S
InventorsEmily L. Bellhouse, Graeme L. J. Paterson
Original AssigneePowderject Research Limited
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Injector
US D428650 S
Abstract  available in
Images(2)
Previous page
Next page
Claims(1)
  1. The ornamental design for an injector, as shown and described.
Description

FIG. 1 is a perspective view of an injector viewed from the upper front left side showing our new design;

FIG. 2 is a perspective view of the injector viewed from the lower front left side;

FIG. 3 is an elevational right side view thereof;

FIG. 4 is an elevational front view thereof;

FIG. 5 is an elevational left side view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof; and,

FIG. 8 is an elevational rear view thereof.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7255865Jan 17, 2002Aug 14, 2007Allergan, Inc.Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction
US7479281Oct 4, 2006Jan 20, 2009Allergan, Inc.Locally administering botulinum toxin powder to a patient using a using a needleless syringe connected to a tank of compressed inert gas, such as helium, for producing a supersonic gas flow; gold, platinum, tungsten or ice crystal carrier; pain is alleviated within 1 to 7 days of administration
US8025889Dec 19, 2008Sep 27, 2011Allergan, Inc.Botulinum toxin administration to treat various conditions
US8420105Aug 18, 2011Apr 16, 2013Allergan, Inc.Botulinum toxin administration to treat various conditions
Classifications
U.S. ClassificationD24/112, D24/113, D24/114